Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living FacilitiesMyron S. Cohen, Jason Morris, Mary Marovich et al.|JAMA|2021Cited by 208
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemiaSaroj Vadhan‐Raj, Eric Roeland, Rafat Abonour et al.|Journal of Hematology & Oncology|2017Cited by 88